Skip to main
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 37%
Hold 21%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is the largest provider of acute-care hospitals in the United States, with a wide network of facilities and strong financial flexibility. Despite transient challenges, such as the impact of flu and weather on Q1:26 results, HCA remains on track to meet its 2026 targets thanks to expected growth from newly approved state-directed payment programs and the ongoing outpatient expansion. With strong cash flow and a robust pipeline for future investments, the company has a promising outlook for long-term growth and profitability, supporting an upbeat outlook.

Bears say

HCA Healthcare is facing several headwinds that are negatively impacting its financial performance. The company has experienced a decline in admissions and emergency room visits due to the flu and weather in the first quarter, leading to a $180 million impact on EBITDA. The company also faced a $150 million headwind from HIX, with a 15% decline in Exchange admissions. The company's labor costs, professional fees, and supplies are also expected to be higher in the future, potentially leading to a contraction in its valuation multiple. Overall, these factors could result in lower than expected financial performance and may lead to a decrease in the stock price.

HCA Healthcare (HCA) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 37% recommend Buy, 21% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 19 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $523.68, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $523.68, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.